Ann: Fujifilm Exercises License Option in GvHD, page-304

@Malotru

I think a couple of things...in the post.

1. DFU/TekCyte detail - more must be coming...lack of details so far
2. Cell Contract - A$1.623m Oz in a single contract is LARGE for us (given $5m over 6 yrs previously)....and the info only triggered by the need for board approval at Waisman of US$1m + contracts so LARGE for them too.
3. What's the FDA part in the contract? (Board have stated FDA goal 2021)

My assumption was also must be Fuji getting ready for GvHD in Japan (sigh). but that trial is likely only 40-50 patients. therefore the contract size is interesting, and also the mention of FDA work.
I do think cells for OA and MEND are already stored in Oz.

It wouldn't take much for an update on intended use for a big spend.
They last did one end Dec 2020.

Why should we keep guessing?

I'm not sure why Cynata is now so gun-shy of regular updates on operational progress.
Just bring up the list of announcements over last 3/6/12 months....with so much happening, we get less now than when we were just running GvHD P1.

News flow brings momentum and confidence. and less whingers
Look at say RAC comms.